Deciphera Pharmaceuticals (DCPH) Earnings
|
Expand Research on DCPH
| Next EPS Date | 5/1/24 | EPS Growth Rate | +8.3% |
|---|---|---|---|
| Average EPS % Beat Rate | +4.9% | Revenue Growth Rate | +37.7% |
| Average % Move 1-Wk after EPS | +10.6% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/4/20 |  |
Q220 | -$1.20 | -$1.37 | +$0.17 | $7.1M | $890K | N/A |  | | Details |
| 2/8/22 | |
Q421 | -$1.51 | -$1.33 | -$0.18 | $24.2M | $23.29M | N/A | | | Details |
| 11/5/20 | |
Q320 | -$1.13 | -$1.30 | +$0.17 | $15.5M | $7.05M | N/A | | | Details |
| 11/2/21 | |
Q321 | -$1.37 | -$1.28 | -$0.09 | $23.2M | $23.36M | N/A | | | Details |
| 5/5/20 | |
Q120 | -$1.36 | -$1.25 | -$0.11 | $62K | $210K | N/A | | | Details |
11/4/19  |
|
Q319 | N/A | -$1.18 | N/A | N/A | $500K | N/A | N/A | N/A | |
| 3/9/20 | |
Q419 | -$1.31 | -$1.18 | -$0.13 | N/A | $1.15M | N/A | | | Details |
| 2/9/21 | |
Q420 | -$1.10 | -$1.15 | +$0.05 | $19.5M | $18.93M | N/A | | | Details |
